Clinical Trial

China Health Big Data

Study acronym: China biobank
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 17, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
In this nationwide multi center study the investigators combine the low dose chest CT scan data with QCT technology, to measure the BMD of spine, VAT and liver fat in the health check subjects. The aim of this study is to evaluate the performance of QCT in the health check field, and further to evaluate the prevalence of osteoporosis, obesity and liver steatosis in health check population across China.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2018-10-05; most recent amendment 2025-08-13.
Trial Details
NCT Number NCT03699228
Lead Sponsor Beijing Jishuitan Hospital
Collaborators: Chinese PLA General Hospital, Ruijin Hospital, Huashan Hospital, Henan Provincial People's Hospital, The Affiliated Hospital Of Guizhou Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, The First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital Xi'an Jiaotong University, The renmin hospital of wuhan university, Nanjing BenQ Hospital, China-Japan Friendship Hospital, xinan hospital, Wu Hu Yijishan hospital, The fifth affiliated hospital of zhong shan university
Conditions Osteoporosis, Obesity, Liver Steatoses
Enrollment 30,000 participants
Start Date 2017-12-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-17